로딩 중…
StockDiggingStockDigging

KUKJEON PHARMACEUTICAL Co.,Ltd

307750· KOSDAQ
₩2,305-3.56%
2026-06-19

Price Chart

KUKJEON PHARMACEUTICAL Co.,Ltd-39.18%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap124.44B KRW
Revenue127.43B KRW
Net Income-8.49B KRW
Total Assets188.79B KRW
Net Assets107.87B KRW
Employees175
Value
P/B1.15x
P/S0.98x
FCF Yield0.94%
Profitability
ROE-7.87%
ROA-4.49%
Op. Margin-0.02%
Revenue Growth-9.44%
Earnings Growth-412.56%
Financial Health
Debt Ratio175.01%
Total Debt39.48B KRW
FCF1.17B KRW
Cash11.11B KRW
Current Ratio1.32x
Dividend
Div. Yield0.38%
Div. Growth0.00%
Performance
1Y Return-39.18%
1M Return-23.04%
From 52W High-61.58%
1Y MDD-58.39%
Trading
Volume249,450 shares
Foreign Own.1.46%
Per Share
EPS-156 KRW
BPS1,975 KRW

Company Info

CEO 홍종호
Employees 175
Founded 2018
HQ 경기도 안양시, KR

Kukjun Pharm, established in 1995 and listed on KOSDAQ in 2020, is a chemical total solution company. Utilizing chemical synthesis technology, it produces active pharmaceutical ingredients (APIs), OLED materials, semiconductor materials, and secondary battery electrolyte additives, operating in both pharmaceutical and material business sectors. The company is conducting Phase 1 clinical trials for an Alzheimer's treatment with Shaperon and Phase 3 clinical trials for a combination treatment with TH Pharm, and constructed a factory in Eumseong-gun in 2023 for the commercial production of materials for AI semiconductor processes. Kukjun Pharm is headquartered in Anyang-si, Gyeonggi-do.